BR9101118A - Produto contendo um ou mais veiculos de enzimas e anticorpos ou fragmentos de anticorpos,e processo para atacar um alvo - Google Patents
Produto contendo um ou mais veiculos de enzimas e anticorpos ou fragmentos de anticorpos,e processo para atacar um alvoInfo
- Publication number
- BR9101118A BR9101118A BR919101118A BR9101118A BR9101118A BR 9101118 A BR9101118 A BR 9101118A BR 919101118 A BR919101118 A BR 919101118A BR 9101118 A BR9101118 A BR 9101118A BR 9101118 A BR9101118 A BR 9101118A
- Authority
- BR
- Brazil
- Prior art keywords
- antibodies
- enzymes
- target
- fragments
- vehicles
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6815—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy
- A61K47/6885—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy the conjugate or the polymer being a starburst, a dendrimer, a cascade
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4283—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/94—Involves covalent bonding to the substrate
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Birds (AREA)
- Biotechnology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Cosmetics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicinal Preparation (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB909006328A GB9006328D0 (en) | 1990-03-21 | 1990-03-21 | Cell killing |
| GB909021671A GB9021671D0 (en) | 1990-10-05 | 1990-10-05 | Delivery of agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9101118A true BR9101118A (pt) | 1991-11-05 |
Family
ID=26296815
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR919101118A BR9101118A (pt) | 1990-03-21 | 1991-03-21 | Produto contendo um ou mais veiculos de enzimas e anticorpos ou fragmentos de anticorpos,e processo para atacar um alvo |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0450800B1 (enExample) |
| JP (1) | JPH04234821A (enExample) |
| AT (1) | ATE139704T1 (enExample) |
| AU (1) | AU642979B2 (enExample) |
| BR (1) | BR9101118A (enExample) |
| CA (1) | CA2038577C (enExample) |
| DE (1) | DE69120452T2 (enExample) |
| ES (1) | ES2088464T3 (enExample) |
| IN (1) | IN172886B (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9021671D0 (en) * | 1990-10-05 | 1990-11-21 | Unilever Plc | Delivery of agents |
| AU642980B2 (en) * | 1990-03-21 | 1993-11-04 | Quest International B.V. | Ultilization of enzymes |
| US5486360A (en) * | 1993-04-22 | 1996-01-23 | St. Joseph Health Centre | Method of treating tumour cells using catalase |
| AU1194697A (en) * | 1995-12-21 | 1997-07-17 | Quest International B.V. | Particle compositions |
| US5972355A (en) * | 1997-09-30 | 1999-10-26 | E-L Management Corp. | Stable compositions containing biologically active components |
| US5871714A (en) * | 1997-10-16 | 1999-02-16 | Pharmacal Biotechnologies, Inc. | Compositions for controlling bacterial colonization |
| EP1787627A1 (en) | 2005-11-17 | 2007-05-23 | 3M Innovative Properties Company | Anti-microbial dental impression material |
| ES2784495T3 (es) | 2010-12-20 | 2020-09-28 | Dupont Us Holding Llc | Generación enzimática de perácidos para su uso en productos para el cuidado bucodental |
| EP2655646A4 (en) | 2010-12-20 | 2014-05-21 | Du Pont | TARGETED PERHYDROLASES |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1433593A (en) * | 1972-06-09 | 1976-04-28 | Royal College Of Surgeons | Conjugates |
| US4657853A (en) * | 1984-09-14 | 1987-04-14 | E. I. Du Pont De Nemours And Company | Immunoassays utilizing covalent conjugates of polymerized enzyme and antibody |
| ES2054678T5 (es) * | 1986-08-18 | 1997-09-16 | Dow Chemical Co | Conjugados estrella. |
| US4943525A (en) * | 1987-11-02 | 1990-07-24 | Bioventures, Inc. | Simultaneous immunoassay for the determination of antigens and antibodies |
| SE461570B (sv) * | 1988-06-06 | 1990-03-05 | Rama Bio Link Ab | Farmaceutiskt preparat och konjugat av en baktericid och en antikropp |
| WO1990003185A1 (en) * | 1988-09-28 | 1990-04-05 | Ideon Corporation | Combination enzyme immunotherapeutics |
-
1991
- 1991-03-18 AU AU72996/91A patent/AU642979B2/en not_active Ceased
- 1991-03-19 CA CA002038577A patent/CA2038577C/en not_active Expired - Fee Related
- 1991-03-20 JP JP3130820A patent/JPH04234821A/ja active Pending
- 1991-03-20 DE DE69120452T patent/DE69120452T2/de not_active Expired - Fee Related
- 1991-03-20 EP EP91302397A patent/EP0450800B1/en not_active Expired - Lifetime
- 1991-03-20 AT AT91302397T patent/ATE139704T1/de not_active IP Right Cessation
- 1991-03-20 ES ES91302397T patent/ES2088464T3/es not_active Expired - Lifetime
- 1991-03-21 BR BR919101118A patent/BR9101118A/pt not_active Application Discontinuation
- 1991-03-21 IN IN84BO1991 patent/IN172886B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU7299691A (en) | 1991-10-03 |
| AU642979B2 (en) | 1993-11-04 |
| EP0450800A1 (en) | 1991-10-09 |
| CA2038577A1 (en) | 1991-09-22 |
| ATE139704T1 (de) | 1996-07-15 |
| IN172886B (enExample) | 1993-12-25 |
| ES2088464T3 (es) | 1996-08-16 |
| CA2038577C (en) | 2001-06-19 |
| JPH04234821A (ja) | 1992-08-24 |
| EP0450800B1 (en) | 1996-06-26 |
| DE69120452D1 (de) | 1996-08-01 |
| DE69120452T2 (de) | 1996-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001294541A1 (en) | Mammalian genes; related reagents and methods | |
| ATE309349T1 (de) | Chemokinrezeptor 88c sowie dessen antikörper | |
| DE69737683D1 (de) | Antikörper gegen die ed-b domäne von fibronektin, ihre herstellung und verwendungen | |
| AU691995B2 (en) | Interference-suppressing reagent specific to certain classes of antibodies | |
| DE69631468D1 (de) | Nachweiss von antikörper gegen bakterielle antigene durch fluoreszenz-polarisation | |
| NO962560L (no) | Materialer og metoder ved påvisning av stpahylococcus aureus | |
| EA200000196A1 (ru) | Универсальная плазма крови | |
| DE69433301D1 (de) | Methoden zur erhöhung der biologischen aktivität von chemokinen | |
| CY1109093T1 (el) | Πρωτεϊνες των υποδοχεων θηλαστικων, σχετικα αντιδραστηρια και σχετικες μεθοδοι | |
| BR0007035A (pt) | Métodos de controle de pragas de agrótis | |
| ATE309365T1 (de) | Hiv-1 der gruppe 0, entsprechende fragmente dieses virus,sowie deren anwendungen | |
| AU642979B2 (en) | Utilization and delivery of enzymes | |
| DE69119817D1 (de) | Verwendung von Enzymen | |
| FI873410A0 (fi) | Kahden uuden hybridooman tuottamia apolipoproteiini-B-spesifisiä monoklonaalisia vasta-aineita | |
| DE60017019D1 (de) | Antikörper gegen Spaltprodukte von Vimentin | |
| WO1999046379A3 (en) | Human receptor proteins; related reagents and methods | |
| BR9101117A (pt) | Produto que compreende um ou mais veiculos de material enzimatico e processo para distribuir um agente ativo a um sitio | |
| DE69430259D1 (de) | Neuer kalium-kanal-agonist, der von trichoderma virens gewonnen wird | |
| BR0305685A (pt) | Processo para tratamento de materiais de rejeitos contendo halogênio | |
| ATE110786T1 (de) | Monoklonaler antikörper gegen exotoxin a von pseudomonas aeruginosa. | |
| FI956041A0 (fi) | Kompositiot ja diagnostiset menetelmät, joissa käytetään monoklonaalisia vasta-aineita CD44V6 vastaan | |
| AU7000798A (en) | Pharmaceutical antigen-antibody preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EG | Technical examination (opinion): publication of technical examination (opinion) | ||
| FC | Decision: refusal | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. A CLASSIFICACAO IPC ANTERIOR ERA A61K 7/28. Ipc: A61K 8/66 (2006.01), A61K 47/68 (2017.01), A61Q 11 Ipc: A61K 8/66 (2006.01), A61K 47/68 (2017.01), A61Q 11 |